What therapeutic area does Ciprofloxacin target?

Ciprofloxacin is an antibiotic that belongs to the fluoroquinolone class, which is specifically designed to target bacterial infections. Its mechanism of action involves inhibiting the bacterial DNA gyrase and topoisomerase IV, enzymes crucial for bacterial DNA replication and cell division. This makes it particularly effective against a variety of gram-negative and some gram-positive bacteria, which is why its therapeutic area is focused on treating infections rather than the other areas mentioned.

In contrast, cardiovascular disease, neurological disorders, and hormonal imbalances are not addressed by Ciprofloxacin. These conditions require different classes of medications that target the specific pathophysiological mechanisms involved in those therapeutic areas. Thus, Ciprofloxacin's primary use in managing infections confirms its classification in the therapeutic area of infections.